Stock Taper
OABIW
OMNIAB, INC.
NASDAQ
$0.39
▲ UP 0.98% (0.00)

KEY STATISTICS

Market Cap$2.48 B
52w High$0.39
52w Low$0.17
Dividend Yield
Frequency
P/E-0.84
Volume100
Shares Out.144.97M

COMPANY

LEADERSHIP

Matthew W. Foehr
CHIEF EXECUTIVE
Matthew W. Foehr

COMPENSATION 2026

Salary$563,542
Stock Awards$410,156
Incentive Plan Pay$394,479
All Other Comp.$7,828
Total$2,647,424

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 30, 2021
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
89

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.$3.43M
NOV
17
TUE

PRICE

$0.39 ▲ UP 0.98% (+$0.00)
$0.34$0.36$0.38$0.3910:28 AM11:04 AM11:41 AM12:17 PM12:53 PM1:30 PM2:06 PM0.39

About OmniAb, Inc.

https://www.omniab.com ↗

OmniAb, Inc. provides innovative antibody discovery platforms using genetically engineered transgenic animals to enable the development of next-generation therapeutics and bispecific antibodies.

INDUSTRY

Biotechnology

A PRODUCT OMNIAB, INC. IS KNOWN FOR

OmniUltra
OmniUltra

OmniUltra, OmniAb's advanced platform using engineered chickens, enables novel antibody and peptide discovery to develop next-generation therapeutics like bispecifics, CAR-T, and radioligands targeting challenging biological sites.

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q4-2025Q2-2026
Service$1.95M $1.94M $3.38M $2.47M
Royalty$188K $111K $579K $266K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

OFFICER: CHIEF OPERATING OFFICER
Nwachuku Amechi Ekeke
Purchase · 800.0K shares
2026-08-01
OFFICER
Nwachuku Amechi Ekeke
· —
2026-07-13
DIRECTOR
Gotwals Philip J
Purchase · 20.0K shares
2026-06-17
DIRECTOR
Bertozzi Carolyn R
Purchase · 20.0K shares
2026-06-17

SECTORS PEERS

PEERPRICE
VOR$24.85COMPARE
OBIO$4.92COMPARE
CGEN$2.58COMPARE
IVVD$0.81COMPARE
TARA$3.94COMPARE
CHRS$1.42COMPARE
MDWD$13.29COMPARE
NTHI$5.15COMPARE